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Western herbal medicine consultations for common menstrual problems; practitioner 
experiences and perceptions of treatment  
 
 






Objective: To explore the prevalence with which Australian Western herbalists treat 
menstrual problems and their related treatment, experiences, perceptions and inter-
referral practices with other health practitioners. 
 
Methods: Members of the Practitioner Research and Collaboration Initiative (PRACI) 
practice-based research network identifying as Western Herbalists (WHs) completed a 
specifically developed, on-line questionnaire.  
 
Results: WHs regularly treat menstrual problems, perceiving high, though differential, 
levels of effectiveness. For menstrual problems WHs predominantly prescribe 
individualised formulas including core herbs, like Vitex agnus-castus, and problem-
specific herbs.  Estimated clients’ weekly cost (median= $25.00) and treatment 
duration (median= 4-6 months) covering this Western herbal medicine (WHM) 
treatment appears relatively low. Urban-based women are more likely than those 
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rurally-based to have used conventional treatment for their menstrual problems 
before consulting WHs (p=0.001). Only 19% of WHs indicated direct contact by 
conventional medical practitioners regarding treatment of clients’ menstrual problems 
despite 42% indicating clients’ conventional practitioners recommended consultation 
with WH.  
 
Conclusion: WHM may be a substantially prevalent, cost-effective treatment option 
amongst women with menstrual problems. A detailed examination of the behaviour of 
women with menstrual problems who seek and use WHM warrants attention to 
ensure this health care option is safe, effective and appropriately co-ordinated within 





On average women experience monthly menstrual cycles for around four decades of 
their lives, typically only interrupted by pregnancies, lactation practices, mental and/or 
physical health problems (Rowland, Baird et al. 2002). Whilst menstrual cycles can vary 
in length and bleeding duration, the majority of women (between 80 – 97%) will in 
addition experience problematic symptoms, associated with menstruation at some 
point within these years (Milewicz and Jedrzejuk 2006) .  Premenstrual syndrome 
(PMS) and dysmenorrhoea are the most commonly reported conditions, with 
prevalence rates of around 50% (Taylor 2005, Direkvand-Moghadam, Sayehmiri et al. 
2014) and up to 91% (Ju, Jones et al. 2014) respectively, but heavy and/or irregular 
menstruation are also frequently experienced (Milewicz and Jedrzejuk 2006).  
 
PMS is a set of symptoms occurring any time post-ovulation and prior to menstruation 
which resolves at the start of bleeding or some days after its onset. The symptoms may 
be physical, mental, behavioural, emotional or combinations of any number of these 
(Taylor 2005). Irregular menstrual periods vary from the normal regular cycle where 
bleeding occurs every 21 to 35 days and/or are associated with altered bleeding 
patterns such as inter-menstrual bleeding or prolonged bleeding (Dovom, Tehrani et 
al. 2016). Heavy periods have been defined as the loss of more than 80 ml of 
menstrual blood per cycle which left unchecked results in iron deficiency with its 
widespread, concomitant health consequences (Fraser, Mansour et al. 2015).  Without 
being able to quantify blood loss, an alternative definition of heavy menstrual bleeding 
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relates to excessive menstrual blood loss that interferes with aspects of women’s 
normal daily function and quality of life (Munro 2017). Dysmenorrhoea, cramp-like 
pelvic pain associated with menstruation, occurs just prior to bleeding or for up to 
three days into bleeding, and can radiate to other parts of the lower pelvic area or 
upper legs (Stewart and Deb 2016). Due to CPPD there are days in the cycle when 
women’s lives are impacted through mood disturbances, reduced resilience to stress 
and lack of ability to perform or concentrate on normal daily tasks affecting family, 
social and professional life (Sharp, Taylor et al. 2002). These functional losses have a 
further economic cost to women, through extra out-of-pocket medical and self-
treatment expenses and lost work-days (Heinemann, Minh et al. 2012), and to the 
state from reduced levels of productivity (Fraser, Langham et al. 2009) and increased 
health care costs. For example 0.4% of Danish health expenditure went on treating 
heavy menstrual bleeding alone in 2005 (Fraser, Langham et al. 2009). 
 
Individual menstrual symptoms, which have been numbered at over 200 (Taylor 2005), 
have largely been examined in isolation and initiatives within the field of gynaecology 
have sought to bring these under the single umbrella term of Cyclic Perimenstrual Pain 
and Discomfort (CPPD) (Sharp, Taylor et al. 2002). The widespread nature and variable 
frequency of perimenstrual symptoms, has led many women to seek multiple 
solutions. These have included using conventional medicine such as pharmaceuticals, 
surgery and psychological counselling which can have limitations in terms of efficacy 
(Kaunitz, Rowe et al. 2008, Fraser, Mansour et al. 2015), risks of adverse events 
(Marjoribanks, Ayeleke et al. 2015) and implications for future fertility or conception 
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(Sharp, Taylor et al. 2002, Munro 2017); self-help therapies such as heat packs, 
analgesics and dietary supplements (Sharp, Taylor et al. 2002); and treatment offered 
beyond conventional medicine such as acupuncture and massage therapy (Fisher, 
Sibbritt et al. 2016). These options may be used on their own by women at different 
times or concurrently as complementary therapy.  There was a noted fall in medical 
prescription rates for PMS in the United Kingdom between 1993-1998 (Wyatt, 
Dimmock et al. 2002),  a decline which continued till 2013 (Sammon, Nazareth et al. 
2016). Data from North America, France and Germany also support reduced rates of 
PMS diagnosis from 2004-2006 indicative of lower consultation rates by women and at 
odds with reported PMS prevalence (Weisz and Knaapen 2009). These findings may be 
illustrative of a move by women to find alternative, non-pharmaceutical solutions.  
 
Complementary and alternative medicine (CAM) includes a range of diverse health-
related strategies that can be described as predominantly operating outside the 
conventional medical curriculum and medical profession (WHO 2013). Women are 
predominant adopters of CAM with prevalence rates amongst Australian women 
having risen significantly between 1993 and 2004 (MacLennan, Myers et al. 2006). 
Direct evidence of varying quality exists for the efficacy of a variety of CAM in treating 
menstrual problems including acupuncture, aromatherapy, nutritional supplements 
and WHM for dysmenorrhoea and PMS (Fugh-Berman and Kronenberg 2003, Izzo, 




Traditional herbal medicine is considered one of the oldest CAM modalities, with its 
ethnic diversity reflecting the flora present in specific geographical locations and its 
practices often enshrined in local pharmacopoeias. Whilst WH practice is largely self-
regulated worldwide, governing bodies have been established to oversee the quality of 
education and define ethical and practice limitations. Treatment strategies are holistic, 
addressing both the mental and physical aspects of an individual’s health. Whole 
medicinal plant parts may be used as teas, tablets and/or as alcohol/water extracts – 
tinctures - which are the predominant form used in modern practice, usually blended 
into individualised formulations. Official endorsement and promotion of its use has 
come from the World Health Organisation (WHO 2013). WHM use is increasing 
worldwide, predominantly amongst women (MacLennan, Myers et al. 2006). It has 
been suggested that women’s increased uptake of  non-prescription alternatives for 
PMS coupled with a concomitant rise in visits to WHM clinics, may be possible 
explanations for the drop-off in UK prescription rates for PMS (Wyatt, Dimmock et al. 
2002). Further to this, a survey undertaken around this time reported PMS was one of 
the main health problems being treated by WHs (Barnes and Ernst 1998). Additionally, 
indirect evidence from cross-sectional studies conducted worldwide suggests women 
are adopting WHM to specifically address commonly experienced menstrual symptoms 
(Fisher, Sibbritt et al. 2016).  Indeed, there is gathering evidence of the beneficial role 
that WHMs may have in treating aspects of CPPD (Izzo, Hoon-Kim et al. 2016). Clinical 
trials (Schellenberg, Zimmermann et al. 2012) and a recent review (Izzo, Hoon-Kim et 
al. 2016) for example suggest chaste tree (Vitex agnus-castus) is a potentially beneficial 
treatment for PMS, a condition for which it is routinely prescribed by German doctors 
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(Schellenberg, Zimmermann et al. 2012). There is however a dearth of robust, clinical 
trials of herbal medicine in treating CPPD with many studies lacking good methodology 
and associated with risks of bias. Whilst systematic reviews have concluded, that 
within these limitations, herbal medicines may have significant benefits over placebo 
and in some cases equivalence with conventional medicine in terms of efficacy, they 
are largely considered inconclusive due to lack of quality studies (Javan, Yousefi et al. 
2016, Verkaik, Kamperman et al. 2016). 
 
Given the health burden and cost to women it is important to examine all health-
seeking behaviours with a view to ensuring that women are using oral medicines 
appropriately and with proper guidance regarding effective dosages and potential 
interactions if they are used concurrently. The objective of our study was to assess 
WHs consultations with women for the menstrual-related disorders of PMS, 
dysmenorrhoea, irregular and heavy periods, with a focus on examining the 
prevalence, perceptions, experiences and inter-referral practices of WHs regarding 
treatment. Our analyses provide the first insights regarding the behaviour and role of 





A subset of practitioners, identifying as WHs, from the Practitioner Research and 
Collaboration Initiative (PRACI) were surveyed between November 2016 and January 
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2017. PRACI is an Australian national database of 14 CAM professions whose individual 
members elected to join what is the largest practice-based complementary healthcare 
research network worldwide (Steel, Adams et al. 2014).  There are currently 764 PRACI 
members representing a 60% uptake of those initially invited to participate after 
completing the 2015 baseline survey. Participants and non-participants were not 
significantly different in terms of age, gender, urban/rural location, qualifications but 
there were some geographical discrepancies. WH participants were more often urban 
based and are less well spread geographically than the general CAM workforce (Steel, 
Sibbritt et al. 2017). Based on data from the profile of WHs in Australia carried out in 
2014 (Leach, McIntyre et al. 2014), PRACI WH participants represent a small 
proportion of those practitioners registered with the main Australian, WHM 
professional body.  
 
 
Ethical approval for this survey was granted by the Human Ethics Committee at the 
University of Technology Sydney (UTS HREC ETH16-0534).  
 
PRACI members registered as currently practising as WHs at the time of this survey were 
invited to participate in this sub-study into their treatment of specific menstrual 
problems (PMS, dysmenorrhoea, irregular and heavy menstruation), by electronically 
receiving a new, specifically designed, self-administered, on-line questionnaire.  Identity 
codes used by PRACI ensured anonymity of participant data and access to survey 
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responses were processed only by lead researchers and stored on a private secure, 
electronic device. 
The questionnaire was pilot tested by a sample of experienced herbalists who after 
completing the survey provided feedback on all aspects of the questionnaire including 
content, topics enquired into and practical aspects of completing the survey in terms 
of comprehensibility, provision of responses and time to complete. The questionnaire 
therefore has face validity. Note that none of the questionnaire items measure skills, 
knowledge, abilities, personality traits, or judgements. Nor do they measure clinical or 
personal phenomena of individualised patient care (i.e. psychometric or clinometric 
factors). The questionnaire received approval by the PRACI steering committee prior to 
its being sent out. 
 
The survey had a brief explanation that highlighted the background issues of CPPD and 
its goals before leading into the questionnaire. The questionnaire consisted of 51 
questions and encompassed a range of measures of practitioner characteristics and 
questions specifically related to the treatment of menstrual problems.  
 
Questionnaire format 
The questionnaire comprised of five sections, as outlined below. There were no 
compulsory questions. Practitioners were advised that their participation in the survey 







Data was gathered on age, gender, practitioners’ clinic(s) location and qualifications. 
 
Practice details 
Practitioners were asked to indicate if they worked alone or with other practitioners in 
their clinic(s) and about their clinic in terms of size, including other practitioners and 
client numbers, client make-up and duration of consultations. 
 
Treatment of Specific menstrual problems 
Questionnaire items explored WHs’ diagnostic confidence and methodology, routine 
enquiry of menstrual history, numbers of affected clients identified as having 
menstrual issues, treatment approaches, perceived treatment efficacy and instruments 
used for this assessment, the advantages, disadvantages and potential side-effects of 
treatment, herbs most frequently prescribed for each problem, average treatment cost 
and treatment duration, consultation frequency and sources used to access the latest 
relevant research. 
 
Interaction with other practitioners 
Practitioners were asked about their inter-disciplinary formal contact with other health 
professionals and their cross-referral patterns and attitudes to contact with 
conventional health practitioners. Practitioners were also asked about the importance 
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of scientific research with regards to herbal treatment of CPPD, and the extent to 
which such research altered their prescribing practices. 
  
Perceived client behaviour 
Practitioners’ knowledge of clients’ behaviour was explored including their clients’ 
previous conventional treatment, concurrent use of WHM with conventional 
treatment, motivations and reasons for choosing WHM treatment. 
 
Menstrual problems 
The menstrual symptoms of PMS, dysmenorrhoea, heavy and irregular periods were 
selected for study as these symptoms were considered those that occur commonly, 
are cyclical and largely idiopathic in nature.  
 
Statistical analyses  
Bivariate analyses were carried out using either Fisher’s exact test or Wilcoxon rank 
sum, where appropriate. Statistical significance was at =0.05. All statistical analyses 
were conducted using Stata 14.2.  
 
Results 
From the PRACI database, 98 Australian-based WHs were eligible and invited to 
participate in our study, of these six invitations were returned “undeliverable”. The 




Professional demographics and practice details 
The breakdown of demographic data by gender is shown in Table 1. Most respondents 
were female (73%), urban-based (69%), sole practitioners (60%), with a predominantly 
female client base (78%), around half of whom were in their reproductive years. The 
majority of WHs worked from urban locations (73%) and operated from a single clinic 
(65%). No WHs were the sole CAM practitioners in a conventional medical setting. 
WHs with degrees or higher qualifications in WHM comprised around 40% of 
respondents. Comparing this demographic data with that from the much larger study 
published in 2014 (Leach, McIntyre et al. 2014)  our participants are representative of 
the wider WH practitioners in Australia in terms of location (p=0.4702) and age 
(p=0.0868) but there was a lower proportion of females (p=0.0306). In addition, 
although our survey appears to identify fewer graduate level or higher qualified 
practitioners (p<0.001) this is likely to be because information sought in the two 
questionnaires are not directly comparable, our questionnaire sought the respondents’ 
highest qualification in herbal medicine whereas the NHAA study enquired into the 
highest educational qualification.   
 
Treatment of menstrual problems 
WHs reported the monthly average number of women who specifically sought 
treatment for menstrual issues was 15 (median=6) and the average weekly estimate of 
the number of women who the WHs believed were suffering with menstrual problems 
was 4.7 (median=5). The approach to WHM prescription for women with menstrual 
issues varied amongst the WHs. Up to 40% of the WHs included a prescription for a 
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single herb (median=10%) and between 2-90% (median= 35%) employed pre-
formulated, proprietary products as part of their treatment, but no WHs relied on 
either of these forms of herbal product by themselves to treat women’s menstrual 
issues. Most WHs (median=70%) included a prescription for a combination of herbs, 
tailored to the woman’s needs, whilst 20% used individualised formulas exclusively. 
However, the majority of WHs (42%) employed a combination of all three types of 
herbal formulations in their treatment of women with menstrual problems. The 
average estimated weekly cost to clients for herbal medicine prescriptions to treat 
menstrual complaints ranged from $5.00 to $75.00 (median=$25.00) with a median 
treatment duration of between 4 to 6 months (data not shown).  
 
The characteristics of WHs relating to evaluation of their training and confidence in 
treating menstrual symptoms are presented in Table 2. Comprehensiveness of 
professional training and diagnostic confidence in the four named menstrual 
symptoms were rated positively by most respondents. However, WHs with diplomas or 
advanced diplomas were significantly more confident in diagnosing irregular periods 
(p=0.026), heavy periods (p = 0.009) and dysmenorrhoea (p = 0.034) than those WHs 
whose qualifications were at degree or higher level.  
 
Table 3 shows the characteristics of WHs practice and assessment of treatment for 
menstrual problems. Treatment efficacy was rated highest for PMS, where it was 
deemed ‘always effective’ by 84% of WHs; with 81%, 71% and 61% rating treatment as 
‘always effective’ for dysmenorrhoea, irregular periods and heavy periods respectively.  
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The ‘always effective’ rating compared across symptoms was statistically significantly 
different between PMS and heavy periods only (p = 0.010). In terms of diagnostic 
methods used respondents use of standard diagnostic tests (p=0.6574), Diagnostic and 
Statistical Manual of Mental Disorders (DSM) or other validated questionnaires 
(p=0.7832), charts (p=0.3878) and client history taking (p=0.5656) were no different 
across the menstrual problem concerned. There was also no difference in the 
distribution of frequency of efficacy of herbal treatments across the menstrual 
problems (p=0.2992) or in the respondents’ believed benefits of their use of herbal 
medicine for treating the different menstrual problems (p=0.9999). 
  
 
Whilst nearly all WHs relied on clients’ self-evaluation to assess treatment efficacy, 
questionnaires were used by 27% and laboratory testing by 40% as additional aids. 
Those WHs who used established tools to diagnose any of the menstrual conditions 
were also more likely to use laboratory testing and/or questionnaires to evaluate 
treatment efficacy (p = 0.045). However, whilst this associated likely use of tools to 
assist in diagnosis and evaluation is true also for the individual problems of PMS (p = 
0.017), heavy periods (p = 0.005) and dysmenorrhoea (p = 0.027), the likelihood does 
not hold for respondents in relation to irregular periods (p = 0.164) (data not shown). 
 
Table 4 lists the herbs most often prescribed by WHs for each menstrual symptom. 
Whilst a small number of herbs such as Vitex agnus-castus, Paeonia lactiflora, Actaea 
racemosa and Angelica sinensis were reported as those most often prescribed by WHs 
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to cover the treatment of all four symptoms, other herbs that were commonly 
prescribed were specific to the prevailing symptom.  
 
Side-effects of herbal medicines were cited by 10% of WHs as one of the drawbacks to 
their treatment. For all side-effects enquired into WHs perceptions were that these 
were largely ‘never’ or ‘rarely’ reported back to them by their clients being treated for 
menstrual problems. However, of those side-effects that were ‘sometimes’ reported to 
them by these same women 23% indicated this to be for nausea, 19% for diarrhoea, 
10% for bloating, 6% for headaches and 3% for insomnia. Respondents were invited to 
add reports of other side-effects not listed resulting in a further five instances, which 
were skin rash (1), initial worsening of symptoms (2), upset stomach (1) and vomiting 
(1). The frequency of these events was not specified by respondents. 
 
Interaction with other health practitioners regarding treatment of patients with 
menstrual problems 
Frequency of formal contact to other CAM health practitioners and conventional 
health practitioners, as reported by participants, was 48% and 35% respectively. 
Contact initiated by conventional health practitioners to WHs (19%) was reported to 
be less frequent than contacts to WHs from other CAM therapists (45%). WHs who 
indicated they received more frequent levels of contact (‘sometimes / often’) initiated 
by conventional health practitioners were also more likely than those indicating that 
this contact occurred ‘rarely / never’ to have a practice with an average of 21 or more 
clients per week (p = 0.043). This association between practises of 21 or more was not 
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significantly related to frequent contact from other CAM practitioners (p = 0.233) or 
where frequency of contact from WHs was to CAM practitioners (p = 0.252) or to 
conventional practitioners (p = 0.217) (data not shown).  When asked which health 
practitioners were known to have recommended their services, or that of any WH, to 
treat menstrual symptoms 68% of WHs reported other CAM practitioners as the main 
source, while 45% recorded recommendations coming from general practitioners and 
26% that medical specialists had made the recommendation.    
 
Referral patterns of clients by WHs to other practitioners were predominantly to 
general practitioners (57%), followed by other CAM professionals (40%) and 
counsellors (23%) with 20% making referrals to women’s clinics (20%). The majority of 
WHs (74%) indicated they were comfortable in communicating with their clients’ 
conventional health practitioners, and 71% that such collaboration was desirable. 
Nearly all WHs (97%) reported always or sometimes encouraging their clients to 
disclose their WHM use to their conventional medical practitioner.  
 
Most WHs (94%) reported enquiring with their clients about whether the client had 
already consulted a medical practitioner for their presenting menstrual problem(s) and 
of these, the percentage of clients estimated to have received conventional medicine 
prior to approaching the WH varied widely (mean=64%, median=70%). WHs practising 
in urban settings were more likely than those practising in rural settings to respond 
that over half of their clients had received conventional medical treatment for their 
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This paper reports findings from the first survey to examine WHM consultations for the 
treatment of common menstrual problems as well as their expectations of treatment 
duration, costs, actual herb choices, diagnostic assessments, perceptions of the 
benefits and adverse events of WHM and inter-referral practises. Some interesting 
points arise from our analyses and are discussed below. 
 
According to responding WHs an average of 15 women per month per practitioner 
specifically sought help for menstrual problems. In addition, WHs also estimated they 
identified, on average, around 20 women per month (five women per week) in their 
consultations who they believed suffered menstrual problems. It is therefore possible 
an additional number of affected women are being identified during consultation 
whose primary reason for seeking the services of a WH is not around menstrual issues. 
Also from this data it is likely that WHs are regularly treating these prevalent menstrual 
problems. A survey of UK WHs in 1997 identified PMS as one of the leading conditions 
treated (Barnes and Ernst 1998) and another in 2010 indicated that women made up 
on average 67% of WHs’ client base and of these 59% were seeking help to treat 




Between 2004 and 2006, based on reliable health care data derived from five different 
countries, the actual diagnosis of PMS and its more severe form, Premenstrual 
Dysphoric Disorder (PMDD), made annually by conventional medical practitioners 
represented less than 0.1% of all women’s consultations irrespective of nationality 
(Weisz and Knaapen 2009). PMS itself has a prevalence of around 50% (Taylor 2005) 
and that of PMDD is estimated at between 3-9% (Milewicz and Jedrzejuk 2006, 
Kaunitz, Rowe et al. 2008).  In spite of the fact that some women included in the Weisz 
and Knaapen calculation would have fallen outside the relevant age range for 
menstruation the finding still suggests conventional consultation rates are very low. In 
1998 the rate of prescription-linked diagnosis of PMS in the West Midlands of the UK 
was estimated at 0.42% of all women in the area, this was lower than the same data 
collected in 1993 (Wyatt, Dimmock et al. 2002). Furthermore according to a 2014 
Australian survey of a large GP population that claims to provide the ‘most 
comprehensive and objective’ measure of GP activity worldwide, the mean duration of 
consultations reported was 14.4 minutes and almost 60% of these consultations dealt 
with a single health problem (Britt H 2014). The relatively short consultations, no 
doubt inherent in busy conventional medical settings, are likely to preclude 
questioning into women’s menstrual histories if this is not the presenting issue. By 
contrast, the relatively long consultations and routine questioning around 
menstruation, as reported in our survey of WHs, improve the likelihood of exposing 
undiagnosed or untreated menstrual problems. Based on data provided by WHs in our 
survey a relatively higher proportion of women they treat may be receiving WHM for 
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their menstrual disorders than the proportion being treated by conventional medical 
practitioners. These factors may have significance for the possible efficacy of and/or 
preference by women to treat menstrual problems with WHM and further research is 
warranted to arrive at a better understanding of the import of these data. 
 
As perceived by practitioners, WHM appears associated with few, relatively minor side 
effects regarding menstrual problem treatment. This view is currently supported for 
some herbs by independent assessment (Izzo, Hoon-Kim et al. 2016).  However, this is 
a field still requiring greater corroboration. Comparisons of conventional medicine 
rates for effective treatment of all four menstrual issues have been reported as 
variable across reviews (Sharp, Taylor et al. 2002, Yonkers, O'Brien et al. 2008, 
Marjoribanks, Lethaby et al. 2016) and/or to be subject to significant risk of side 
effects (Taylor 2005, Kaunitz, Rowe et al. 2008, Marjoribanks, Ayeleke et al. 2015) and 
in the case of hormone therapies such as oral contraceptives and GnRH 
(gonadotrophin-releasing hormone) agonists (Yonkers, O'Brien et al. 2008), and 
surgery (hysterectomy or oophorectomy) (Yonkers, O'Brien et al. 2008) carry the 
significant drawback of being unsuitable for women contemplating  pregnancy. Not 
only have health service managers acknowledged that CAM practitioners can bridge 
gaps in their service and improve holistic care and choices for clients (Singer and 
Adams 2014) but  some general and specialist conventional health practitioners have 
endorsed having CAM options available for treating gynaecological issues (Münstedt, 
Maisch et al. 2014). Scope may therefore exist for increased treatment options for 
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women but further investigation involving suitable clinical trials of WHM would be a 
pre-requisite.  
 
Our analyses do suggest that referrals between conventional medical practitioners and 
WHs are already occurring, although perceived warning signs/reasons for referral were 
not part of this survey and should be examined in more detail in the future to assess 
the safety of WH practice. A 2013 Australian survey of an organisation representing a 
range of natural health practitioners recorded only 2% of their respondents worked in 
clinics which included conventional medical practitioners (Grace, Rogers et al. 2013) 
much lower than the 25% recorded in our survey. One possible interpretation of our 
finding is that herbalists may be more frequent participants in multidisciplinary clinics 
which include conventional medical practitioners than CAM practitioners from other 
modalities. Another is that the level of WHs integration into this type of clinic may 
have risen significantly, supported by data from a 2004 naturopath/herbalists survey  
where 7% identified as working in this type of multidisciplinary environment 
(Bensoussan, Myers et al. 2004).  Increased integration of WHs into multidisciplinary 
clinics in either case may indicate that conventional medical practitioners have 
increasingly found WHs of benefit to their healthcare provision. Further research is 
needed to clarify this situation.  
 
The uncertain and multi-factorial aetiology of menstrual symptoms has led to over 300 
therapies being prescribed as part of conventional medical treatment (Milewicz and 
Jedrzejuk 2006).  These include the use of a variety pharmaceuticals such as anti-
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depressants and hormone therapy (oral and/or implants), alongside symptom-specific 
treatments such as analgesics, diuretics and/or anti-fibrinolytics and possibly also 
psychological, dietary and lifestyle support and/or surgery (Sharp, Taylor et al. 2002, 
Taylor 2005, Kaunitz, Rowe et al. 2008). In addition, treatment choices can be further 
complicated as women often experience several perimenstrual issues concurrently. 
This has prompted gynaecology specialists to recommend the adoption of 
individualised strategies in conventional treatment of women with CPPD. 
Individualised treatment is highlighted in this survey by WHs predominantly using 
herbal blends. Such blends allow for a range of menstrual symptoms to be addressed 
within a single formulation. Furthermore, WHM has a long tradition contained in 
historical Pharmacopoeias attesting to the use of herbs to enhance women’s 
reproductive health. However, in scientifically assessing individualised treatment, 
whether conventional or WHM,  new and different research methodology centred on 
overall ‘wellness’ is required, such as that espoused by Whole Systems Research 
(Verhoef, Lewith et al. 2005). This research approach was developed in response to the 
sophisticated technological advances enabled by gene mapping and focuses on the 
more complex outcome of  “maximizing patients’ capacity to achieve mental and 
physical balance”, as the endpoint measure of a treatment’s efficacy (Verhoef, Lewith 
et al. 2005). Such a patient-based approach would regard the whole package of care, 
from all sources, as the intervention to be assessed and would provide an appropriate 
model with which to evaluate individualised treatment strategies. The field of 
integrative health is increasingly becoming a research interest as patients’ preferences 




As the standard current conventional treatments normally employed may not resolve 
the range of symptoms equally effectively, women with CPPD are often prescribed a 
variety of strategies and/or pharmaceuticals (Kaunitz, Rowe et al. 2008, Yonkers, 
O'Brien et al. 2008), involving multiple health professionals (Marjoribanks, Lethaby et 
al. 2016).  Up to 30% of women with heavy menstrual bleeding are estimated to seek 
medical help during their reproductive lives (Laberge, Leyland et al. 2015). The current 
recommended first line treatments are endometrial ablation or hormone implant 
devices. However, of the women treated using these therapies up to 20% (Hussain, 
Barnes et al. 2016) and 60% (Marjoribanks, Lethaby et al. 2016) respectively have been 
found to go on to receive hysterectomies. Both implants and surgery require costly, 
high-level medical care. Idiopathic menstrual problems have a high prevalence and can 
require  long-term treatment (Kaunitz, Rowe et al. 2008, Yonkers, O'Brien et al. 2008), 
their direct and indirect costs are undoubtedly significant (Liu, Doan et al. 2007). In 
addition to medical costs, women pay an extra price through their reduced 
participation in work/school and social life, morbidity and disability (Sharp, Taylor et al. 
2002, Liu, Doan et al. 2007). Prescribing practices across four nations highlighted that 
when women choose to consult conventional health practitioners for PMS, 72-89% 
received prescriptions, as compared to 59-78% for all women patients whose 
consultations result in a prescription (Weisz and Knaapen 2009). Heavy menstrual 
bleeding alone is estimated to account for over 5% of 30-49 year-old UK women 
consulting their doctors each year and a further 12% of gynaecology referrals (Grant, 
Gallier et al. 2000). Within conventional costs for the initial treatment of menstrual 
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problems there are potential additional expenses from unintended side-effects. For 
example, to the already considerable expense generated by high hysterectomy levels 
secondary costs can arise from associated surgical complications, some of which may 
have very serious health consequences (Spilsbury, Semmens et al. 2009, Marjoribanks, 
Lethaby et al. 2016). Western Australia hospital records from 2000-3 recorded re-
admission rates of 7.2%, following hysterectomies, due to complications (Spilsbury, 
Semmens et al. 2009). From the data gathered in our survey we have projected the 
costs reported by WHs for WHM treatment, taking average duration (4-6 months) and 
average, weekly cost per client this computes to between AUD $453 - AUD $680, 
excluding practitioner fees. As the Australian governmental health insurance, 
Medicare, covers Australian residents for conventional healthcare whilst both public 
and private provision for WH consultations is much more limited, for some women this 
cost may not be insubstantial. However, for health providers responsible for covering 
such costs, these figures appear to be very modest if WHM treatment should prove to 
be viable and effective in the long-term. Comparable data to that estimated above for 
WHM for conventional treatment would be near impossible to determine particularly 
when addressing multiple symptoms simultaneously but our data suggests that 
relative costs associated with WH treatment compared to current conventional costs 
could provide a beneficial cost-to-benefit ratio. This important topic deserves further 
investigation to establish both the overall cost of treatment of these wide-spread 
menstrual problems to achieve short term symptom-resolution as well as the 




There are limitations to our study not least of which is the low response rate although 
this rate is similar to previous surveys of CAM therapists which have reported response 
rates of around 35% (Leach, McIntyre et al. 2014). Our sample size is small and limited 
to English-speaking practitioners and as such may not fully represent the geographical 
spread of WHs throughout Australia. Larger studies are needed to corroborate our 
findings. In terms of the demographic profile and clinic details of participating WH 
practitioners our data is broadly in line with similar surveys using larger Australian 
samples (Grace, Rogers et al. 2013, Leach, McIntyre et al. 2014) with the possible 
exceptions that our sample has under-represented females and over-represented 
older practitioners when comparing these specific demographics to one previous WH 
survey (Leach, McIntyre et al. 2014). Selection bias is possible given the voluntary 
nature both of membership to the PRACI database and those practitioners completing 
our sub-study questionnaire possibly limiting the generalizability of the findings. 
Respondents were not asked specifically about identifying serious risks associated with 
menstrual issues that would require referral for detailed medical investigation, a 
limitation associated with the questionnaire itself. Finally, the information obtained 
from our survey is self-reported and so may be subject to recall and confirmation bias. 
However, these limitations are countered by the information obtained from our study 
providing the first examination of WHs’ treatment of patients with menstrual 
problems. 




Based on the perceptions of WHs in our survey, WHM could represent a potentially 
viable option in the treatment of common menstrual problems if its lack of serious 
side-effects and efficacy can be corroborated by robust, independent research. WHM 
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Table 1: Demographics of WHs by gender  
Demographic Practitioners  NHAA 
Survey(Leach, 
McIntyre et al. 
2014)  




Total Female              
Male 
346 (86.7%)       53 
(13.3) 
Age in years (n=36) 
40 years of younger 
40 years or older 






Mean 50.6 (SD=9.06) 53.3 (SD=9.94) 51.4 (SD=9.25)  
Clinic description (n=40)     
One 19 (65.5%) 7 (63.6%) 26 (65.0%) N/A 
More than one 10 (34.5%) 4 (36.4%) 14 (35.0%)  
Clinic location (n=40)     
Urban 20 (69.0%) 9 (81.8%)    29 (72.5%) 188 (63.3%) 
Rural 10 (34.5%) 4 (36.4%)   14 (35.0%) 109 (36.7%) 
Remote   0 (0.0%) 0 (0.0%)   0 (0.0%)  
Qualifications (n=40)     
None (grandfathered)   0 (0.0%) 1 (9.0%) 1 (2.5%)  3 (0.01%)  
Diploma   4 (14.0%)  0 (0.0%) 4 (10.0%) 110 (27.6%)*  
Advanced diploma 15 (52.0%)  4 (36.0%) 19 (47.5%) - 
Bachelor degree   7 (24.0%)  0 (0.0%) 7 (17.5%) 148 (37.1%) 
Postgraduate degree   3 (10.0%)  6 (55.0%) 9 (22.5%) 138 (34.6%) 
Years since this Qualification 
(n=39)  
    
1 – 5 years   8 (28.0%)   1 (10.0%) 9 (22.5%) N/A 
6 – 10 years   8 (28.0%)   5 (50.0%) 13 (32.5%)  
11 – 15 years  4 (14.0%)   4 (40.0%) 8 (20.0%)  
16 years or more  9 (30.0%)   0 (0.0%) 9 (22.5%)  
Clinic setting     
Sole practitioner 18 (62.0%)   6 (55.0%) 24 (60.0%)  
Sole CAM practitioner in 
conventional practice 
  0 (0.0%)   0 (0.0%)  0 (0.0%) N/A 
Multimodality clinic with 
conventional 
  7 (24.0%)   3 (27.0%) 10 (25.0%)  
Multimodality clinic with other 
CAM 
  4 (13.0%)   3 (27.0%)   7 (17.5%)  
No. of other practitioners if not 
sole practitioner 
  1 -17 (median=4)   1 -15 
(median=6) 
1 -17 (median=4.5)  
Skype consultations (n=39)     
Yes 16 (57.0%) 6 (55.0%) 22 (56.4%) N/A 
No 12 (43.0%) 5 (45.0%) 17 (43.6%)  
Number of clients per week 
(n=40) 
    
0 – 5 4 (14.0%)  1 (9.0%)  5 (12.5%)  
6 – 10 8 (28.0%)  4 (36.0%) 12 (30.0%) N/A 
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* The NHAA survey combined diploma and advanced diploma and does not specify the 
qualification relates to herbal medicine.
11 – 20 10 (34.0%)  3 (27.0%) 13 (32.5%)  
21 – 40  6 (21.0%)  2 (18.0%)   8 (20.0%)  
More than 40 1 (3.0%)  1 (9.0%) 2 (5.0%)  
Women clients (%) (n=39) 50 – 90 (mean=79%) 60 – 90 
(mean=76%) 
50-90 (78%) N/A 
Women of menstruating age 
(%) (n=40) 
20 – 90 (mean=55%) 15 – 90 
(mean=53%) 
15-90 (54%) N/A 














60 – 90 
(median=60) 
  0 (0.0%) 
  8 (72.7%) 
  1 (9.0%) 
  2 (18.1%) 
  0 (0.0%) 
40 - 120 
(median=72) 
  2 (5.0%) 
20 (50%) 
  3 (7.5%) 
  13 (32.5%) 




 93 (32.1%) 
46 (15.9%) 
15 (5.2%) 







20 – 60 (median=45) 
0 (0.0%) 
11 (37.9%) 
 7 (24.1%) 
11 (37.9%) 
0 (0.0%) 
30 – 60 
(median=30) 
  0 (0.0%) 
 6 (54.5%) 
 2 (18.1%) 
 3 (27.2%) 
 0 (0.0%) 
20 - 60 (median=43) 
0 (0.0%) 
17 (42.5%) 





  98 (33.8%) 
110 (37.9% 
   69 (23.8%) 




Diploma = Diploma or Advanced diploma. 
Degree = Degree or Postgraduate degree. 










 Highest qualification in 
Herbal Medicine 
Highest qualification in 
Herbal Medicine 
 Highest qualification in Herbal 
Medicine 
Highest qualification 





























































































































  6 (20) 






























































































  8 (26%) 
  9 (29%) 






  8 (26%) 













































Benefits of treatment (n=31) 
 
Very effective 
Few side effects 
Holistic way to better health 










































Table 4: Herbs most often prescribed by WHs to treat specific menstrual symptoms 
Herbs used Botanical Name Premenstrual Syndrome Irregular periods Heavy periods Dysmenorrhoea 
  Frequency % Frequency % Frequency % Frequency % 
Chaste tree Vitex agnus-castus 21 80.8 22 84.6 11 42.3 8 30.8 
Peony Paeonia lactiflora 7 26.9 10 38.5 3 11.5 8 30.8 
Crampbark Viburnum opulus 3 11.5     16 61.5 
Bupleurum Bupleurum falcatum 4 15.4       
Shatavari Asparagus racemosa 2 7.7 6 23.1   2 7.7 
Passionflower Passiflora incarnata 3 11.5       
Black cohosh Actaea racemomsa 5 19.2 5 19.2 3 11.5 4 15.4 
Dong quai Angelica sinensis 6 23.1 5 19.2 4 15.4 10 38.5 
Indian ginseng Withania somnifera 6 23.1 3      
St John’s wort Hypericum perforatum 7 26.9       
Chinese foxglove Rehmannia glutinosa 3 11.5 2 7.7     
Magnolia berry Schizandra sinensis 2 7.7       
Skullcap Scutellaria lateriflora 2 7.7       
False unicorn root Chamaelirium luteum   3 11.5     
Liquorice Glycyrrhiza glabra   6 23.1     
True unicorn root Aletris farinosa   2 7.7     
Lady’s mantle Alchemilla vulgaris     11 42.3 2 7.7 
Shepherds purse Capsella bursa-pastoris     11 42.3   
Beth root Trillium pendulum     4 15.4   
Yarrow Achillea millefolium     4 15.4   
Black haw Viburnum prunifolium       2 7.7 
Tienchi Panax notoginseng     4 15.4   
Raspberry leaf Rubus idaeus     2 7.7   
Golden seal Hydrastis canadensis     2 7.7   
Wild yam Dioscorea villosa       8 30.8 
Turmeric Curcuma longa       3 11.5 
Blue cohosh Caulophyllum        2 7.7 
Ginger Zingiber officinale       4 15.4 
Corydalis Corydalis ambigua       3 11.5 
Pukatea Laurelia novae-zelandiae       2 7.7 
 
(Frequency = number of times the herb was mentioned for each condition. % respondents = practitioners who selected the herb as a percentage of those responding to this section) 
 
